ADMA Biologics Inc (NASDAQ:ADMA)

8.46
Delayed Data
As of May 22
 +0.02 / +0.24%
Today’s Change
7.16
Today|||52-Week Range
14.00
-24.26%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$90.6M

Company Description

ADMA Biologics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of human plasma and plasma-derived therapeutics. The company's targeted patient populations include immune-compromised individuals who suffer from an underlying immune deficiency disease or who may be immune-suppressed for medical reasons. It also operates an FDA-licensed, GHA-certified source plasma collection facility. The company was founded by Adam S. Grossman and Jerrold B. Grossman on June 2, 2006 and is headquartered in Hackensack, NJ.

Contact Information

ADMA Biologics, Inc.
465 State Route 17
Ramsey New Jersey 07446-2012
P:(201) 478-5552
Investor Relations:

Employees

Shareholders

Mutual fund holders7.59%
Other institutional24.18%
Individual stakeholders11.62%

Top Executives

Adam S. GrossmanPresident, Chief Executive Officer & Director
Brian LenzChief Financial Officer & Vice President
James MondExecutive VP, Chief Scientific & Medical Officer

To view my watchlist

Not a member yet?

Sign up now for a free account